目的探讨抗HBV特异性主动免疫疗法对标准重组乙型肝炎（乙肝）疫苗无应答者的免疫效果。
Objective To investigate the effects of anti-HBV specific active immunotherapy on non-responsive persons immunized with standard recombinant hepatitis B vaccine.
急性乙肝患者特异性细胞免疫功能明显强于慢性乙肝患者及肝炎肝硬化患者。
The specific cellular immunity was stronger in the patients with acute hepatitis B than in those with chronic hepatitis B and liver cirrhosis.
结论：用体外免疫法制备乙肝病毒特异性转移因子工艺稳定，制备的转移因子符合质量标准，具有对乙肝病毒抗原的特异性。
Conclusion: the method is simple and stable, whose product of the specific transfer factor of HBV met the quality standard with specific immune activity to HBV-antigen.
结论：用体外免疫法制备乙肝病毒特异性转移因子工艺稳定，制备的转移因子符合质量标准，具有对乙肝病毒抗原的特异性。
Conclusion: the method is simple and stable, whose product of the specific transfer factor of HBV met the quality standard with specific immune activity to HBV-antigen.
应用推荐